KP Biosciences' Unattributed - II Round

KP Biosciences raised a round of funding on January 11, 2018.

KP Biosciences is a broad-spectrum antiviral company that is developing treatments for some of the world's most problematic infectious diseases, including pox viruses and herpes viruses.…

Articles about KP Biosciences' Unattributed - II Round: